These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9014994)

  • 1. Acute conversion of atrial fibrillation and flutter: direct current cardioversion versus intravenously administered pure class III agents.
    Singh BN
    J Am Coll Cardiol; 1997 Feb; 29(2):391-3. PubMed ID: 9014994
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter.
    DeCara JM; Pollak A; Dubrey S; Falk RH
    Am J Cardiol; 2000 Sep; 86(6):685-8, A8. PubMed ID: 10980226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
    Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
    Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.
    Falk RH; Pollak A; Singh SN; Friedrich T
    J Am Coll Cardiol; 1997 Feb; 29(2):385-90. PubMed ID: 9014993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter.
    Murdock DK; Schumock GT; Kaliebe J; Olson K; Guenette AJ
    Am J Cardiol; 2000 Feb; 85(4):503-6, A11. PubMed ID: 10728961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter.
    Suttorp MJ; Polak PE; van 't Hof A; Rasmussen HS; Dunselman PH; Kingma JH
    Am J Cardiol; 1992 Feb; 69(4):417-9. PubMed ID: 1734660
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.
    Obel OA; Camm AJ
    Drugs Aging; 1998 Jun; 12(6):461-76. PubMed ID: 9638394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].
    Vergara G
    Ital Heart J Suppl; 2001 Mar; 2(3):322-3. PubMed ID: 11307794
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction: acute treatment of atrial fibrillation and flutter--ibutilide in perspective.
    Waldo AL; Pratt CM
    Am J Cardiol; 1996 Oct; 78(8A):1-2. PubMed ID: 8903268
    [No Abstract]   [Full Text] [Related]  

  • 11. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
    Vinson DR; Lugovskaya N; Warton EM; Rome AM; Stevenson MD; Reed ME; Nagam MR; Ballard DW;
    Ann Emerg Med; 2018 Jan; 71(1):96-108.e2. PubMed ID: 28969929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical cardioversion of atrial fibrillation and atrial flutter: manoeuvres and tips to increase its effectiveness.
    Korantzopoulos P
    Europace; 2020 Oct; 22(10):1601-1602. PubMed ID: 32728704
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
    Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
    J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute treatment of atrial fibrillation and flutter.
    Anderson JL
    Am J Cardiol; 1996 Oct; 78(8A):17-21. PubMed ID: 8903271
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical cardioversion of atrial fibrillation and atrial flutter: manoeuvres and tips to increase its effectiveness-Authors' reply.
    Brandes A; Crijns HJGM; Rienstra M; Kirchhof P; Grove EL; Pedersen KB; Van Gelder IC
    Europace; 2020 Oct; 22(10):1602. PubMed ID: 32754759
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
    Lindeboom JE; Kingma JH; Crijns HJ; Dunselman PH
    Am J Cardiol; 2000 Apr; 85(8):1031-3. PubMed ID: 10760352
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
    Arnar DO; Danielsen R
    Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
    Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
    Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of urgent cardioversion for patients with recent-onset atrial fibrillation and flutter.
    Stiell IG; Healey JS; Cairns JA
    Can J Cardiol; 2015 Mar; 31(3):239-41. PubMed ID: 25592853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.